Novel RORgamma agonists enhance anti-tumor activity of adoptive T cell therapy

被引：0

作者：

Carter, Laura ^{[3
]}

Moisan, Jacques ^{[3
]}

Majchrzak, Kinga ^{[2
]}

Hu, Xia ^{[3
]}

Morgan, Rodney ^{[3
]}

Liu, Xikui ^{[3
]}

Demock, Kellie ^{[3
]}

Wang, Yahong ^{[3
]}

Lesch, Chuck ^{[3
]}

Sanchez, Brian ^{[3
]}

Bousley, Dick ^{[3
]}

Taylor, Clarke ^{[3
]}

Van Huis, Chad ^{[3
]}

Skalitzky, Don ^{[3
]}

Aicher, Tom ^{[3
]}

Toogood, Peter ^{[3
]}

Zou, Weiping ^{[1
]}

Paulos, Chrystal ^{[2
]}

Glick, Gary ^{[3
]}

机构：

[1] Univ Michigan, Ann Arbor, MI 48109 USA

[2] Med Univ South Carolina, Charleston, SC USA

[3] Lycera Corp, Ann Arbor, MI USA

来源：

JOURNAL OF IMMUNOLOGY | 2015年 / 194卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

TUM2P.1010

引用

页数：2

共 50 条

[1] Bioceramics Enhance the Anti-Tumor Activity of Immune Cells in Adoptive Immunotherapy
Nose, Masato
Nitta, Aiko
Zheng, Yundi
Kizukuri, Rihoko
Nagao, Yuki
Nagai, Shigenori
Aizawa, Mamoru
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (19)
[2] Bispecific T cell recruiting antibody enhances anti-tumor activity of adoptive T cell transfer
Kobold, S.
Steffen, J.
Chaloupka, M.
Grassmann, S.
Henkel, J.
Castoldi, R.
Zeng, Y.
Chmielewski, M.
Schmollinger, J.
Schnurr, M.
Rothenfusser, S.
Schendel, D. J.
Abken, H.
Sustmann, C.
Niederfellner, G.
Klein, C.
Bourquin, C.
Endres, S.
ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 239 - 239
[3] Inducible Enhancement of T Cell Function and Anti-tumor Activity after Adoptive Transfer
Wrangle, John
Paulos, Chrystal M.
Smith, Thomas W., Jr.
Nishimura, Michael I.
Rubinstein, Mark P.
MOLECULAR THERAPY, 2017, 25 (09) : 1995 - 1996
[4] A new bispecific T cell recruiting antibody enhances anti-tumor activity of adoptive T cell transfer
Kobold, S.
Steffen, J.
Lampert, C.
Castoldi, R.
Schmollinger, J. C.
Sustmann, C.
Niederfellner, G.
Klein, C.
Bourquin, C.
Endres, S.
EUROPEAN JOURNAL OF CANCER, 2014, 50 : S213 - S213
[5] Myeloid Suppressor Cell Blockade Potentiates Anti-Tumor Responses of Adoptive T Cell Transfer Therapy
Mok, Steven
Tsui, Christopher
Chodon, Thinle
Ribas, Antoni
Koya, Richard C.
MOLECULAR THERAPY, 2013, 21 : S116 - S116
[6] Discovery of novel STING agonists with robust anti-tumor activity
Li, Anrong
Song, Yuntao
Dong, Chen
Chen, Xiaoqi
Yang, Junbao
CANCER RESEARCH, 2020, 80 (16)
[7] Novel media formulations to enhance Chimeric Antigen Receptor (CAR) T-cell potency and anti-tumor cell function for adoptive immunotherapy
Ghassemi, S.
Martinez-Becerra, F.
Master, A.
Richman, S. A.
Heo, D.
Leferovich, J.
Tu, Y.
Garcia-Canaveras, J. C.
Ayari, A.
Lu, Y.
Wang, A.
Rabinowitz, J. D.
Milone, M. C.
O'Connor, R.
CYTOTHERAPY, 2020, 22 (05) : S133 - S133
[8] Oncolytic adenovirus improves anti-tumor efficacy of adoptive T-cell therapy by breaking tumor tolerance
Tahtinen, S.
Gronberg-Vaha-Koskela, S.
Lumen, D.
Merisalo-Soikkeli, M.
Siurala, M.
Airaksinen, A. J.
Vaha-Koskela, M.
Hemminki, A.
HUMAN GENE THERAPY, 2015, 26 (10) : A33 - A33
[9] Markers of effective anti-tumor CTL populations for adoptive cell therapy
Yang, Jianping
He, Shujie
Peng, Lifeng
Rawson, Pisana
Perret, Rachel
Jordan, Bill
Ronchese, Franca
JOURNAL OF IMMUNOLOGY, 2012, 188
[10] Combination therapy to enhance NK cell anti-tumor responses
Wolf, Natalie K.
Nicolai, Chris
Dang, Susanna
Synder, Gail
Blaj, Cristina
McWhirter, Sarah
Picton, Lora
Garcia, K. Christopher
Raulet, David H.
JOURNAL OF IMMUNOLOGY, 2020, 204 (01):

← 1 2 3 4 5 →